| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |